BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed PHAR catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:ef6352b71eab813dca64@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:PHAR P3 readout (est.): Pediatric Patients Aged 4 to 11 Years With 
 APDS
DESCRIPTION:Pediatric Patients Aged 4 to 11 Years With APDS\nNCT05438407 | 
 PHASE3 | ACTIVE_NOT_RECRUITING | sponsor: Pharming Technologies B.V.\nPrim
 ary completion date (ESTIMATED)\; top-line results usually follow later.\n
 Ticker PHAR (confidence 0.6)\nSource: https://clinicaltrials.gov/study/NCT
 05438407\nScheduling/reference data from public records\; dates can move. 
 Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05438407
CATEGORIES:readout,ESTIMATED
END:VEVENT
BEGIN:VEVENT
UID:904820ef2f4c805b9518@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260911
DTEND;VALUE=DATE:20260912
SUMMARY:PHAR APPROVAL: JOENJA
DESCRIPTION:Approved 2026-09-11: JOENJA (NDA217759 SUPPL6)\nConfidence: con
 firmed\nTicker PHAR (confidence 0.9)\nSource: https://www.accessdata.fda.g
 ov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217759\nSchedu
 ling/reference data from public records\; dates can move. Not investment\,
  legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=217759
CATEGORIES:approval,confirmed
END:VEVENT
END:VCALENDAR
